EGFR-Mutated Lung Cancer Video Perspectives

Thomas Waddington, MD

Waddington reports no relevant financial disclosures.


August 01, 2022
1 min watch
Save

VIDEO: Understanding genetic mutations in lung cancer

Transcript

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

My biggest thing with genetic mutations is my real role is to get enough tissue to evaluate for the genetic mutations. The purpose and what's so amazing about these mutations is if you look at old chemotherapeutic interventions that target every cell in the body, what they're trying to do is get rid of the cancer cells honestly before they damage the rest of the human body. These genetic mutations are these personalized chemotherapeutic, or I should say immunotherapy-based regimens, try to find that mutation and target only that mutation, leaving all the other cells alone. So, my biggest role is to make sure we get enough tissue that that mutation can be evaluated and determined based by the pathologist. We constantly talk about genetic mutations and the regimens we use to treat those, as well as new regimens that are coming out that are trying to treat those.